Philip Morris International Inc

PM remains in a Stage 2 advancing regime following a late-July momentum breakout above mid-June resistance, confirming renewed demand and reinforcing a medium-term bullish bias. However, price is extended well above its rising short-term EMAs and exhibits extreme overbought readings on the Options Score and RSI, making immediate entry unfavorable. Execution favors stalking pullbacks into the rising EMA zone or retest of the prior breakout area. Primary risk is a failure to hold those support levels, which would signal exhaustion of the advance.

• ↑Q1 2026 net revenues $10.15B (+9% YoY), fuelled by smoke-free sales
• ↑Smoke-free volumes up 12.8% YoY; ZYN mix uplift drives growth
• ↓Potential excise tax hikes on nicotine pouches could cut volumes